← Eichor
Study identifier: NCT06336928 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

A Validation Study to Determine Concordance of Liquid Biopsy and Breast Cancer Diagnosis

Condition: Breast Carcinoma  ·  Sponsor: University of Southern California

PhaseN/A
Planned participants490
Who can joinFemale, 18 Years to no upper limit
Healthy volunteersNo

About this study

This study evaluates whether a special type of blood analysis, called liquid biopsy (LBx), correlates with mammography results and/or diagnosis of breast cancer.

This description comes directly from the study's public registry record.

Talk to the study team

Kimberly Arieli, RN  ·  323-865-0451  ·  Kimberly.Arieli@med.usc.edu

Always discuss trial participation with your own doctor first.

Locations (4)

Keck Medicine of USC KoreatownLos Angeles, California, United StatesRecruiting
Los Angeles General Medical CenterLos Angeles, California, United StatesRecruiting
USC / Norris Comprehensive Cancer CenterLos Angeles, California, United StatesRecruiting
USC Norris Oncology/Hematology-Newport BeachNewport Beach, California, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06336928